HopeStage
Back to all studies
UnknownNCT06350396

pBFS-guided rTMS Over DMPFC for Treatment-Resistant Depression

Device studyAges 18–65China
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 65 years.

Listed locations
Hebei and 4 more locationsSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: April 17, 2024
Recruitment status
Unknown
Enrollment listed in the registry
270
Sponsor
Changping Laboratory
Sponsor type
Unknown or unclear
Study type
Device
Intervention type
Device
Locations
China
Age range
From 18 Years to 65 Years
Official registry ID
NCT06350396
Official title
Show the full official title

rTMS Intervention for DMPFC Treatment of Treatment-Resistant Depression Under the Guidance of Personalized Brain Functional Area Dissection (pBFS) Technology

Recruitment & locations

Status unknown

Hebei · Chengdu · Hohhot

2 more locations
  • Jining
  • Xinxiang

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Changping Laboratory.

Who can participate?

Listed age limits: 18 years to 65 years.

Want to explore more studies?

Explore studies